{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:59:13Z","timestamp":1790434753045,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semerg.2026.102798","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:50:18Z","timestamp":1783360218000},"page":"102798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mepifilina in Spain: Accessible evidence, guideline positioning, utilization and proportionate reassessment"],"prefix":"10.1016","volume":"52","author":[{"given":"L.","family":"Richard Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Trillo-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Navarro i Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Maya Viejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2026.102798_bib0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/S0266462318000120","article-title":"Untangling, unbundling, and moving forward: framing health technology reassessment in the changing conceptual landscape","volume":"34","author":"Soril","year":"2018","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.semerg.2026.102798_bib0200","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12913-017-2506-7","article-title":"Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation","volume":"17","author":"Harris","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.semerg.2026.102798_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0266462307080014","article-title":"Exploring policy-makers\u2019 perspectives on disinvestment from ineffective healthcare practices","volume":"24","author":"Elshaug","year":"2008","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.semerg.2026.102798_bib0210","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Fluidasa 5mg\/ml soluci\u00f3n oral: ficha t\u00e9cnica [Summary of product characteristics] [Internet]. Madrid: AEMPS-CIMA. Spanish. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/54498\/FichaTecnica_54498.html [cited 28.5.26]."},{"key":"10.1016\/j.semerg.2026.102798_bib0215","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Fluidasa 20mg\/ml gotas orales en soluci\u00f3n: ficha t\u00e9cnica [Summary of product characteristics] [Internet]. Madrid: AEMPS-CIMA. Spanish. Available from: https:\/\/cima.aemps.es\/cima\/pdfs\/es\/ft\/54499\/54499_ft.pdf [cited 28.5.26]."},{"key":"10.1016\/j.semerg.2026.102798_bib0220","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Fluidasa 150mg c\u00e1psulas duras: ficha t\u00e9cnica [Summary of product characteristics] [Internet]. Madrid: AEMPS-CIMA. Spanish. Available from: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/55465\/FT_55465.html [cited 28.5.26]."},{"key":"10.1016\/j.semerg.2026.102798_bib0225","series-title":"Alimentos y Tecnolog\u00eda M\u00e9dica. Disposici\u00f3n 6182\/10 [Internet]","year":"2010"},{"key":"10.1016\/j.semerg.2026.102798_bib0230","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","article-title":"Theophylline","volume":"188","author":"Barnes","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00002512-199303040-00004","article-title":"The problems of anticholinergic adverse effects in older patients","volume":"3","author":"Feinberg","year":"1993","journal-title":"Drugs Aging"},{"key":"10.1016\/j.semerg.2026.102798_bib0240","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/jpm12020207","article-title":"CRIDECO anticholinergic load scale: an updated anticholinergic burden scale. Comparison with the ACB scale in Spanish individuals with subjective memory complaints","volume":"12","author":"Ramos","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0255","series-title":"Transparency resolution 001-107552: Spanish National Health System billing data for ATC R03DA12, mepifilina, 2022\u20132024","year":"2025"},{"key":"10.1016\/j.semerg.2026.102798_bib0260","series-title":"Historical authorization of 1978","article-title":"Transparency resolution 001-107551: no availability of a public evaluation report","year":"2025"},{"key":"10.1016\/j.semerg.2026.102798_bib0265","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index: R03DA12 mepyramine theophyllinacetate [Internet]. Oslo: Norwegian Institute of Public Health. Available from: https:\/\/atcddd.fhi.no\/atc_ddd_index\/?code=R03DA12 [cited 28.5.26]."},{"key":"10.1016\/j.semerg.2026.102798_bib0270","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0011-393X(02)80011-X","article-title":"Comparison of the efficacy and tolerability of mepifylline oral solution versus inhaled ipratropium bromide in patients with stable chronic obstructive pulmonary disease: a randomized, active-controlled, open-label study","volume":"63","author":"Sampablo","year":"2002","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.semerg.2026.102798_bib0275","first-page":"3","article-title":"Valoraci\u00f3n de la eficacia y seguridad de la mepifilina en soluci\u00f3n oral en ni\u00f1os con crisis de asma de leve a moderada","volume":"22","author":"Sienra Monge","year":"1994","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.semerg.2026.102798_bib0280","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0149-2918(95)80047-6","article-title":"Efficacy and safety of mepyramine\u2013theophylline\u2013acetate in the treatment of asthmatic crisis in children","volume":"17","author":"Sienra-Monge","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.semerg.2026.102798_bib0285","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.semerg.2026.102798_bib0295","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.semerg.2026.102798_bib0300","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.semerg.2026.102798_bib0305","series-title":"The AGREE II Instrument [Internet]","year":"2017"},{"key":"10.1016\/j.semerg.2026.102798_bib0310","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0315","doi-asserted-by":"crossref","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0320","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.semerg.2026.102798_bib0325","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.semerg.2026.102798_bib0330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"10.1016\/j.semerg.2026.102798_bib0335","series-title":"Global Strategy for Asthma Management and Prevention: 2025 update [Internet]","year":"2025"},{"key":"10.1016\/j.semerg.2026.102798_bib0340","series-title":"Global Strategy for Prevention, Diagnosis and Management of COPD: 2026 report [Internet]","year":"2026"},{"key":"10.1016\/j.semerg.2026.102798_bib0345","series-title":"Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115) [Internet]","year":"2018"},{"key":"10.1016\/j.semerg.2026.102798_bib0350","series-title":"Cough (acute): antimicrobial prescribing (NG120) [Internet]","year":"2019"},{"key":"10.1016\/j.semerg.2026.102798_bib0355","series-title":"Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245) [Internet]","year":"2024"},{"key":"10.1016\/j.semerg.2026.102798_bib0360","series-title":"GEMA 5.5: gu\u00eda espa\u00f1ola para el manejo del asma [Internet]","year":"2025"},{"key":"10.1016\/j.semerg.2026.102798_bib0365","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.arbres.2025.10.008","article-title":"Update 2025 of the Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD","volume":"61","author":"Miravitlles","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.semerg.2026.102798_bib0370","series-title":"Global Strategy for Asthma Management and Prevention: 2026 update [Internet]","year":"2026"},{"key":"10.1016\/j.semerg.2026.102798_bib0375","unstructured":"European Medicines Agency. Public data from Article 57 database [Internet]. Amsterdam: EMA. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/data-medicines-iso-idmp-standards-post-authorisation\/public-data-article-57-database [cited 28.5.26]."},{"key":"10.1016\/j.semerg.2026.102798_bib0380","unstructured":"European Medicines Agency. Medicines [Internet]. Amsterdam: EMA; Available from: https:\/\/www.ema.europa.eu\/en\/medicines [cited 28.5.26]."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359326001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:20:18Z","timestamp":1790432418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359326001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1138359326001152"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102798","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepifilina in Spain: Accessible evidence, guideline positioning, utilization and proportionate reassessment","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2026.102798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN).","name":"copyright","label":"Copyright"}],"article-number":"102798"}}